The Valley Desk

Clinical trial reportCancerPublished

A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Coriell Institute for Medical Research. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Phthalazines; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; DNA Methylation; Drug Resistance, Neoplasm; Adult; Aged; Middle Aged; Female; Triple Negative Breast Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors
PubMed ID
41980055
PubMed Central ID
PMC13078666
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal